Pasar al contenido principal

MECANISMOS REGULADORES DE PLASTICIDAD EN MELANOMA. PAPEL DE LOS INDUCTORES DE EMT EN PROGRESION TUMORAL Y RESISTENCIA A TERAPIAS.

SAF2016-75702-R

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2016
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Functional interplay between secreted ligands and receptors in melanoma

  • Herraiz, Cecilia
  • Jiménez-Cervantes, Celia
  • Sánchez-Laorden, Berta
  • García-Borrón, José C.
Melanoma, the most aggressive form of skin cancer, results from the malignant transformation of melanocytes located in the basement membrane separating the epidermal and dermal skin compartments. Cutaneous melanoma is often initiated by solar ultraviolet radiation (UVR)-induced mutations. Melanocytes intimately interact with keratinocytes, which provide growth factors and melanocortin peptides acting as paracrine regulators of proliferation and differentiation. Keratinocyte-derived melanocortins activate melanocortin-1 receptor (MC1R) to protect melanocytes from the carcinogenic effect of UVR. Accordingly, MC1R is a major determinant of susceptibility to melanoma. Despite extensive phenotypic heterogeneity and high mutation loads, the molecular basis of melanomagenesis and the molecules mediating the crosstalk between melanoma and stromal cells are relatively well understood. Mutations of intracellular effectors of receptor tyrosine kinase (RTK) signalling, notably NRAS and BRAF, are major driver events more frequent than mutations in RTKs. Nevertheless, melanomas often display aberrant signalling from RTKs such as KIT, ERRB1-4, FGFR, MET and PDGFR, which contribute to disease progression and resistance to targeted therapies. Progress has also been made to unravel the role of the tumour secretome in preparing the metastatic niche. However, key aspects of the melanoma-stroma interplay, such as the molecular determinants of dormancy, remain poorly understood., Work by the authors is supported by grants SAF2015-67092-R (to CJ-C and JCG-B) and SAF2016-75702-R (to BS-L) from the Mineco (Spain) and FEDER (European Community) and 19875/GERM/15 from the Fundación Seneca, Comunidad Autónoma Región de Murcia (CARM) (to CJ-C and JCG-B). C Herraiz holds a Juan de la Cierva-Incorporación fellowship from Mineco (Spain)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microenvironmental Snail1-induced immunosuppression promotes melanoma growth

  • Arumi-Planas, Marta
  • Rodríguez-Baena, Francisco Javier
  • Cabello-Torres, Francisco M.
  • Graciá Quiles, Francisco
  • López-Blau, Cristina
  • Nieto, M. Ángela
  • Sánchez-Laorden, Berta
Melanoma is an aggressive form of skin cancer due to its high metastatic abilities and resistance to therapies. Melanoma cells reside in a heterogeneous tumour microenvironment that acts as a crucial regulator of its progression. Snail1 is an epithelial-to-mesenchymal transition transcription factor expressed during development and reactivated in pathological situations including fibrosis and cancer. In this work, we show that Snail1 is activated in the melanoma microenvironment, particularly in fibroblasts. Analysis of mouse models that allow stromal Snail1 depletion and therapeutic Snail1 blockade indicate that targeting Snail1 in the tumour microenvironment decreases melanoma growth and lung metastatic burden, extending mice survival. Transcriptomic analysis of melanoma-associated fibroblasts and analysis of the tumours indicate that stromal Snail1 induces melanoma growth by promoting an immunosuppressive microenvironment and a decrease in anti-tumour immunity. This study unveils a novel role of Snail1 in melanoma biology and supports its potential as a therapeutic target., This work was supported by grants SAF2016-75702-R and PID2019-106852-RBI00 (to BS-L), RTI2018-096501-B-I00 and PID2021-125682NB-I00 (to MAN) funded by MCIN/AEI/ 10.13039/501100011033 and ERDF, the Melanoma Research Alliance (https://doi.org/10.48050/pc.gr.91574 to B.S-L), the FERO Foundation (to B.S-L) and the AECC Scientific Foundation (FC_AECC PROYE19073NIE to MAN). MA-P and FC-T were recipients of a FPI predoctoral contract. FJR-B and FG hold contracts from the Generalitat Valenciana (APOSTD and ACIF, respectively). We also acknowledge financial support from the Spanish State Research Agency, through the ‘Severo Ochoa Programme’ for Centres of Excellence in R&D (SEV-2017-0273) and the Generalitat Valenciana through the ‘Prometeo Programme’ for Groups of Excellence (CIPROM/2021/045)., Peer reviewed